BICALUTAMIDE GT 150 MG

BICALUTAMIDE

Public price

1.314,20 MAD

Reimbursement base

1.314,20 MAD

Active substance

BICALUTAMIDE

What is this medicine?

Bicalutamide is a non-steroidal androgen receptor inhibitor used for the treatment of prostate cancer.

Verified summary

BICALUTAMIDE, COMPRIME PELLICULE, 150 MG, 1 BOITE 20 COMPRIME PELLICULE

Common uses

Used in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate.

Class

Non-steroidal androgen receptor inhibitor

Hospital price

869,30 MAD

Strength

150 MG

Form

COMPRIME PELLICULE

Presentation

1 BOITE 20 COMPRIME PELLICULE

Type

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2017-12-18: 1.314,20 MAD

Available presentations and strengths

BICALUTAMIDE GT

150 MG · BOITE DE 20

1,14 MAD

BICALUTAMIDE GT

150 MG · BOITE DE 60

2,58 MAD

BICALUTAMIDE GT

50 MG · BOITE DE 20

326,00 MAD

BICALUTAMIDE GT

50 MG · 1 BOITE 20 COMPRIME PELLICULE

450,00 MAD

BICALUTAMIDE GT

50 MG · BOITE DE 30

478,00 MAD

BICALUTAMIDE GT 50 MG

50 MG · Boîte de 30

478,00 MAD

BICALUTAMIDE GT

50 MG · 1 BOITE 30 COMPRIME PELLICULE

675,00 MAD

BICALUTAMIDE GT

50 MG · BOITE DE 60

903,00 MAD

BICALUTAMIDE GT 50 MG

50 MG · Boîte de 60

903,00 MAD